jnhr journal

AND option

OR option

Current issue

Ahead of print articles

 

JNHR, Volume 8, 2022

 

6th NURSING HOME RESEARCH INTERNATIONAL CONFERENCE - June 2-3, 2022 Toulouse - France

Abstracts

Jour Nursing Home Res 2022;8:S1-S24

Show summaryHide summary



CITATION:
(2022): 6th NURSING HOME RESEARCH INTERNATIONAL conference - June 2-3, 2022 Toulouse - France. The Journal of Nursing Home Research Science (JNHRS). http://dx.doi.org/10.14283/jnhrs.2022.5

OPEN ACCESS

Download PDF (549.47 Ko)

Read more...

DEFINING LIFE-LIMITING ILLNESS IN THE NURSING HOME POPULATION: IDENTIFYING A POPULATION TO BENEFIT FROM PALLIATIVE CARE SERVICES

D.S. Mack, J. Tjia, K.L. Lapane

Jour Nursing Home Res 2022;8:1-5

Show summaryHide summary

Patients with life-limiting conditions often benefit from palliative care to improve quality of life. There is no consensus definition of the term “life-limiting illness” for the nursing home population. The objective of this paper was to provide a framework to define life-limiting illness in the nursing home population using a narrative review. PubMed and GoogleScholar were searched for terms to define: “life-limiting illness,” “serious illness,” and “end-of-life.” Based on peer-reviewed literature, we operationalized the term “life-limiting illness” in the context of the nursing home population into five domains: (1) prognosis-based definitions (i.e. <6 months), (2) mortality risk-based (i.e. high risk vs low risk), (3) healthcare service-based (i.e. receipt of palliative care consult), (4) comorbidity index-based (e.g. the Veteran’s Health Association Palliative Care Index), and (5) composite definition (i.e. comorbidity and caregiver burden).

CITATION:
D.S. Mack ; J. Tjia ; K.L. Lapane ; (2022): Defining Life-Limiting Illness in the Nursing Home Population: Identifying a Population to Benefit from Palliative Care Services. The Journal of Nursing Home Research Science (JNHRS). http://dx.doi.org/10.14283/jnhrs.2022.1

OPEN ACCESS

Download PDF (280.08 Ko)View HTML

Read more...

EDITORIAL: RESEARCH IN NURSING HOMES IN THE TIME OF COVID

Y. Rolland, P. de Souto Barreto

Jour Nursing Home Res 2022;8:6-7

Show summaryHide summary



CITATION:
Y. Rolland ; P. de Souto Barreto ; (2022): Editorial: Research in nursing homes in the time of COVID. The Journal of Nursing Home Research Science (JNHRS). http://dx.doi.org/10.14283/jnhrs.2022.2

OPEN ACCESS

Download PDF (142.78 Ko)View HTML

Read more...

LETTER TO THE EDITOR: VITAMIN D INTAKE AND FALLS AMONG OLDER NURSING HOME RESIDENTS

K. Salminen, U. Aalto, M. Suominen, H. Kautiainen, K. Pitkälä, H.-M. Roitto

Jour Nursing Home Res 2022;8:8-9

Show summaryHide summary

K. Salminen; U. Aalto; M. Suominen; H. Kautiainen; K. Pitkälä; H.-M. Roitto (2022): Letter to the Editor: Vitamin D intake and falls among older nursing home residents. The Journal of Nursing Home Research Science (JNHRS). http://dx.doi.org/10.14283/jnhrs.2022.3

Download PDFView HTML

Read more...

ANTIHYPERGLYCEMIC DRUG USE IN LONG-STAY NURSING HOME RESIDENTS WITH DIABETES MELLITUS

A.L. Hume, S. Osundolire, A.K. Mbrah, A.P. Nunes, K.L. Lapane

Jour Nursing Home Res 2022;8:10-19

Show summaryHide summary

Background: About 29.2% of American adults ≥ 65 years of age have diabetes mellitus, but details regarding diabetes management especially among nursing home residents are dated. Objectives: Evaluate the prevalence of antihyperglycemic agents in residents with diabetes mellitus and describe resident characteristics using major drug classes. Design: Cross-sectional study. Setting: Virtually all United States nursing homes. Participants: 141,636 residents with diabetes mellitus. Measurements: Minimum Data Set (2016) and Medicare Part D claims determined use of metformin, sulfonylureas, meglitinide analogs, alpha-glucosidase inhibitors, TZDs, DPP4 inhibitors, SGLT2 inhibitors, GLP1 agonists, as monotherapy and with basal insulin. Results: Seventy-two percent received antihyperglycemic drugs [most common: basal insulins (53.9% total; 46.9% with other non-insulin agents), metformin (35.5% total; 14.2% monotherapy), sulfonylureas (19.6% total; 6.3% monotherapy), and DPP4 inhibitors (12.2% total; 2.2% monotherapy)]. Sixty-three percent of meglitinide monotherapy versus 34.1% of metformin monotherapy users; and 38.3% meglitinide–basal insulin versus 22.2% metformin–basal insulin users were ≥85 years. Obesity was greater among users of GLP1 agonists compared to those receiving other agents (monotherapy: 60.5% versus 33-42%; with basal insulin: 76.2% versus 50-58%). End-stage renal disease was least prevalent among metformin users (monotherapy: 6.6%; with basal insulin: 8.8%) and most common among meglitinide monotherapy (19.6%) and GLP1 agonists with basal insulin (22%) users. Conclusions: There is heterogeneity of diabetes treatment in nursing homes. Use of antihyperglycemic drugs with a higher risk of hypoglycemia, such as insulin with sulfonylureas or meglitinides, continue in nursing home residents.

CITATION:
A.L. Hume ; S. Osundolire ; A.K. Mbrah ; A.P. Nunes ; K.L. Lapane (2022): Antihyperglycemic Drug Use in Long-Stay Nursing Home Residents with Diabetes Mellitus. The Journal of Nursing Home Research Science (JNHRS). http://dx.doi.org/10.14283/jnhrs.2022.4

OPEN ACCESS

Download PDF (435.4 Ko)View HTML

Read more...

COMORBIDITY AND DEPENDENCE JOINTLY INDICATE THE NEED FOR PALLIATIVE CARE IN NURSING HOME RESIDENTS

V. Guion, P. Riba Bremerch, Y. Rolland

Jour Nursing Home Res 2022;8:20-23

Show summaryHide summary

The purpose was to investigate the association between mortality in nursing home residents (NHR) and multimorbidity, dependence and their interaction. This study was an 18-month prospective, observational study, that included a subgroup of 5527 NHR residing in 163 nursing homes located in France between May and July 2011. A Cox proportional hazard model was used to perform multivariate survival analysis. Independent variables of interest were baseline multimorbidity, baseline dependence, and the interaction between multimorbidity and dependence. NHR were very dependent at baseline and the median Charlson Index score was 2. In multivariate survival analysis, multimorbidity and dependence were both significantly associated with an increased 18-month mortality (HR=1.10; CI 95% [1.04 - 1.17] and HR=1.30; CI 95% [1.22 – 1.38], respectively). Higher multimorbidity and higher dependence were both independently associated with a higher 18-month mortality in NHR. Clinicians could use these two simple indicators to identify NHR requiring palliative care.

CITATION:
V. Guion ; P. Riba Bremerch ; Y. Rolland (2022): Comorbidity and dependence jointly indicate the need for palliative care in nursing home residents. The Journal of Nursing Home Research Science (JNHRS). http://dx.doi.org/10.14283/jnhrs.2022.6

OPEN ACCESS

Download PDF (209.04 Ko)View HTML

Read more...